P
PBYI
Puma Biotechnology Inc
9.06
-0.18-1.95%Closed19:30 08/28 EDT
OPEN/PREV CLOSE9.24/9.24
TODAY RANGE9.02-9.26
VOL235.04K
MARKET CAP467.68M
52 WEEK RANGE4.300-9.51
AVG VOL (3M)322.81K
% TURNOVER0.46%
TURNOVER0
P/E (TTM)17.56
% RANGE2.38%
EPS(TTM)0.5160
P/E(FORWARD)23.84
P/B3.342
BVPS2.711
DIVIDEND--
P/S2.000
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP396.33M
SHARES OUTSTANDING51.62M
NEXT EARNINGS11/04-11/09
FREE FLOAT43.75M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·08/19 00:11
Puma Biotechnology Earnings Call Signals Profitable Momentum
Simply Wall St·08/08 02:45
Puma Biotechnology (PBYI) Stock Jumps On Profit Strength As Earnings Outlook Fades
Dow Jones·08/07 21:18
Puma Biotechnology Is Maintained at Hold by TD Cowen
Benzinga·08/07 21:08
TD Cowen Maintains Hold on Puma Biotechnology, Raises Price Target to $6
TipRanks·08/07 13:26
Puma Biotechnology price target raised to $6 from $5 at TD Cowen
TipRanks·08/06 20:32
Puma Biotechnology sees Q3 revenue $56M-$59M
TipRanks·08/06 20:32
Puma Biotechnology raises FY26 revenue to $224M-$231M from $222M-$229M
Dow Jones·08/06 20:05
Press Release: Puma Biotechnology Reports Second -3-
Dow Jones·08/06 20:05
*Puma Biotechnology 2Q EPS 16c >PBYI
Dow Jones·08/06 20:05
*Puma Biotechnology 2Q Rev $56.5M >PBYI
Dow Jones·08/06 20:05
*Puma Biotechnology 2Q Net $8.2M >PBYI
Benzinga·07/07 21:05
12 Health Care Stocks Moving In Tuesday's After-Market Session
TipRanks·06/16 20:40
Puma Biotechnology Shareholders Back Governance, Reject Warrant Extension